Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.36 |
| ▸ | HMGCR | P04035 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | CPT2 | P23786 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28186949 | 0.89 | TSHR (0.41) | ALDH1A1TSHRFFAR3HMGCRCHRM1 | |
| SCHEMBL1728131 | 0.84 | ALDH1A1 (0.45) | ALDH1A1TSHRFFAR3CYP4F2CYP4A11 | |
| SCHEMBL9015631 | 0.83 | ALDH1A1 (0.36) | ALDH1A1TSHRCYP4F2CYP4A11TDP1 | |
| SCHEMBL27875241 | 0.83 | FFAR3 (0.39) | ALDH1A1TSHRFFAR3HMGCRCHRM1 | |
| SCHEMBL4653162 | 0.82 | ALDH1A1 (0.43) | ALDH1A1TSHRFFAR3CYP4F2CYP4A11 | |
| SCHEMBL5570450 | 0.80 | ALDH1A1 (0.41) | ALDH1A1TSHRFFAR3CYP4F2CYP4A11 | |
| SCHEMBL11515952 | 0.79 | ALDH1A1 (0.50) | ALDH1A1TSHRFFAR3HMGCRCHRM1 | |
| SCHEMBL595137 | 0.78 | HMGCR (0.37) | ALDH1A1TSHRFFAR3HMGCRCHRM1 | |
| SCHEMBL11709719 | 0.78 | ALDH1A1 (0.43) | ALDH1A1TSHRFFAR3HMGCRCHRM1 | |
| SCHEMBL20262480 | 0.77 | CYP4F2 (0.53) | ALDH1A1TSHRHMGCRCHRM1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114921776-A | Chromium-free and fluorine-free film passivator for aluminum material and preparation and use method thereof | 广州旭奇材料科技有限公司 | 2022-08-19 | — | — | CN | claimed |
| CN-118355459-A | Conductive paste composition, method for producing conductive sheet, and method for producing electronic component | 积水化学工业株式会社 | 2024-07-16 | — | — | CN | disclosed |
| US-11970448-B2 | Monomers capable of dimerizing in an aqueous solution, and methods of using same | CORNELL UNIVERSITY (US) | 2024-04-30 | — | — | US | disclosed |
| WO-2023224010-A1 | CONDUCTIVE PASTE COMPOSITION, MANUFACTURING METHOD FOR CONDUCTIVE SHEET, CONDUCTIVE SHEET, AND MANUFACTURING METHOD FOR ELECTRONIC COMPONENT | 積水化学工業株式会社 | 2023-11-23 | — | — | WO | disclosed |
| US-20230339878-A1 | SLC26A3 INHIBITORS AND USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-10-26 | — | — | US | disclosed |
| CN-116854776-A | Fluorescent polypeptide probe and preparation method thereof | 中国人民解放军陆军防化学院 | 2023-10-10 | — | — | CN | disclosed |
| EP-3319934-B1 | PROCESS FOR THE ISOLATION OF LEVULINIC ACID | GFBIOCHEMICALS IP ASSETS B V (NL) | 2023-07-26 | — | — | EP | disclosed |
| CN-110172051-B | IRE-1 alpha inhibitors | 复星弘创(苏州)医药科技有限公司 | 2023-03-07 | — | — | CN | disclosed |
| US-11591304-B2 | SLC26A3 inhibitors and use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-02-28 | — | — | US | disclosed |
| CN-114921776-A | Chromium-free and fluorine-free film passivator for aluminum material and preparation and use method thereof | 广州旭奇材料科技有限公司 | 2022-08-19 | — | — | CN | disclosed |
| WO-2013058824-A1 | MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME | CORNELL UNIVERSITY (US) | 2013-04-25 | — | — | WO | disclosed |
| WO-2012154213-A1 | COFLUORONS AND METHODS OF MAKING AND USING THEM | CORNELL UNIVERSITY (US) | 2012-11-15 | — | — | WO | disclosed |
| EP-1479681-A1 | IMIDAZO(1,2-a)PYRIDINE DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-11-24 | — | — | EP | disclosed |
| EP-0781276-B1 | PYRIMIDINONE DERIVATIVES | BORYUNG PHARM (KR) | 2001-12-12 | — | — | EP | disclosed |
| US-6121055-A | DETECTING COMPOUND IN SAMPLE; MIXING SAMPLE AND CHEMICAL INTERMEDIATE, SEPARATING INSOLUBLE COMPONENT OF MIXTURE, ADDING BINDING COMPONENT AND LABEL TO MIX, SEPARATE BINDING COMPONENT AND LABEL, DETECT BOUND LABEL AND BINDING COMPONENT | ROCHE DIAGNOSTICS CORPORATION (US) | 2000-09-19 | — | — | US | disclosed |
| US-5869476-A | ANGIOTENSIN II ANTAGONISTS; TREATING CARDIOVASCULAR DISORDERS | BORYUNG PHARMACEUTICAL CO., LTD. (KR) | 1999-02-09 | — | — | US | disclosed |
| US-5073341-A | Immunology, diagnosis | BIOTOPE, INC. (US) | 1991-12-17 | — | — | US | disclosed |
| EP-0344276-A1 | METHODS AND DEVICES FOR CONDUCTING ASSAYS | BOEHRINGER MANNHEIM CORPORATION (US) | 1989-12-06 | — | — | EP | disclosed |
| US-4868130-A | DENSITY SEPARATION | BIOTOPE, INC. (US) | 1989-09-19 | — | — | US | disclosed |
| US-3933798-A | Novel bis-pyrazolone oxonol dyes | POLAROID CORPORATION (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11970448-B2 | Monomers capable of dimerizing in an aqueous solution, and methods of using same | CALCOCO2, MDN1, MBNL1 | ALDH1A1 4582/4885TSHR 3797/4885FFAR3 4375/4885 |
| US-20230339878-A1 | SLC26A3 INHIBITORS AND USE THEREOF | SLC26A3, SLC10A2, SLC10A6 | ALDH1A1 2345/4885TSHR 2624/4885FFAR3 512/4885 |
| US-11591304-B2 | SLC26A3 inhibitors and use thereof | SLC26A3, SLC10A2, SLC10A6 | ALDH1A1 2687/4885TSHR 2820/4885FFAR3 567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.